Metastatic Prostate Cancer: Treatment Options.
Journal Paper/Review - Nov 15, 2021
Achard Vérane, Putora Paul Martin, Omlin Aurelius, Zilli Thomas, Fischer Stefanie
Metastatic prostate cancer (PCa) is associated with considerable diminished overall survival (OS). Standard treatment for metastatic PCa has long been androgen deprivation therapy alone, with patients initially responding to this treatment and then progressing to a castration-resistant phase.